#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chemical burn Aspergillus infection Fallopian tube cancer Myeloid leukaemia Fibrous dysplasia of bone Infertility female KBG syndrome Philadelphia chromosome positive White matter lesion Malignant oligodendroglioma Palmoplantar pustulosis Mixed-type liposarcoma Cytokine release syndrome Pseudomyxoma peritonei Peripheral T-cell lymphoma unspecified More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Treatment Encephalitis autoimmune – Basic Information Tuberous sclerosis complex – Diagnostics Mast cell activation syndrome – Treatment Crigler-Najjar syndrome – Trials in Disease Anaplastic thyroid cancer – Diagnostics Marfan’s syndrome – Diagnostics Rhabdomyosarcoma – Trials in Disease Hairy cell leukaemia recurrent – Diagnostics Pulmonary sarcoidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avacopan Etoricoxib GS-4321 Allopurinol Sodium GSK3862995B Nomegestrol Acetate Fluticasone Propionate Methadone Hydrochloride HYDROGEN PEROXIDE 2-DEOXY-D-GLUCOSE Ads-013 Hydrocortisone Hemisuccinate Etuvetidigene Autotemcel Melatonin Indometacin Ph. Eur. Camizestrant Inaxaplin Sitravatinib Malate Remdesivir Donidalorsen More therapies…

    Learn about Your Condition

    Malignant melanoma stage III Carotid arteriosclerosis Meniscus operation Lichen planopilaris Arterial stiffness Optic ischaemic neuropathy Papilloma viral infection Ventricular fibrillation Anogenital dysplasia Adenovirus infection Hyperparathyroidism primary Gastrointestinal melanoma Acute HIV infection Combined immunodeficiency Rasmussen encephalitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University General Hospital Of Thessaloniki Ahepa

University General Hospital Of Thessaloniki Ahepa

1ub Sk Kfpxsvgdek Sbqf Tgdcavjacecol 5hd 3bq Gkonzg

Want to learn more about this study or check if you can participate? Contact us.

  • Study of levofloxacin, ketorolac trometamol, and dexamethasone eye drops for preventing inflammation and infection after cataract surgery in adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Levofloxacin Hemihydrate
    • Levofloxacin
    Greece Italy Poland Spain Sweden

  • A Study to Assess Safety and Efficacy of Surzetoclax Alone or with Etentamig in Adults with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Belgium Czechia France Germany Greece Italy +3

  • A Phase 2a Study of Empasiprubart IV Monotherapy in Adults with AChR‑Ab Seropositive Generalized Myasthenia Gravis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    • Empasiprubart
    Belgium Germany Greece Italy The Netherlands Poland +1

  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rifabutin
    • SULBACTAM SODIUM
    • Ampicillin Sodium
    Croatia Greece

  • A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • Saline
    Greece Hungary Italy

  • A study comparing the effectiveness of brimonidine tartrate and timolol eye drops versus a standard combination in patients with glaucoma or ocular hypertension

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Brimonidine Tartrate
    • Timolol
    • Timolol Maleate
    Greece

  • A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Bulgaria Greece Hungary Norway Romania Spain

  • A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

    Recruiting

    3 1
    Investigated Drugs:
    • Remibrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +19

  • A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Bulgaria Czechia Estonia France +10

  • A study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    • Empasiprubart
    Belgium Germany Greece Italy The Netherlands Poland +1
1 2 3 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!